GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $277,393,000 | +817.5% | 1,278,900 | +411.6% | 1.38% | +315.1% |
| Q1 2017 | $30,235,000 | +82.9% | 250,000 | +69.0% | 0.33% | +74.7% |
| Q4 2016 | $16,531,000 | +301.7% | 147,928 | +377.2% | 0.19% | +216.7% |
| Q3 2016 | $4,115,000 | +12.3% | 31,000 | -22.5% | 0.06% | +20.0% |
| Q2 2016 | $3,663,000 | -15.4% | 40,000 | -33.3% | 0.05% | +22.0% |
| Q1 2016 | $4,329,000 | -41.3% | 60,000 | 0.0% | 0.04% | -58.6% |
| Q2 2015 | $7,370,000 | -62.6% | 60,000 | -75.4% | 0.10% | -68.7% |
| Q3 2014 | $19,727,000 | -47.8% | 244,000 | -30.8% | 0.32% | -42.1% |
| Q2 2014 | $37,820,000 | -4.1% | 352,500 | -46.9% | 0.55% | -29.5% |
| Q1 2014 | $39,422,000 | +62.5% | 664,000 | +13.7% | 0.77% | +54.2% |
| Q4 2013 | $24,259,000 | +139.5% | 584,000 | 0.0% | 0.50% | +141.3% |
| Q3 2013 | $10,127,000 | +105.2% | 584,000 | +4.3% | 0.21% | +118.9% |
| Q2 2013 | $4,934,000 | – | 560,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |